SCHEMBL4903604

SCHEMBL4903604

CCc1ccc(S(=O)(=O)N(CC)c2nc(-c3ccccc3)oc2C)cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ESR1 P03372 1/20 0.40
TARBP2 Q15633 1/20 0.39
POLB P06746 1/20 0.38
PTPN22 Q9Y2R2 2/20 0.38
PTPN1 P18031 1/20 0.38
PTPN12 Q05209 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 2/20 0.37
THRB P10828 1/20 0.37
SLC9A1 P19634 1/20 0.37
BCL2L1 Q07817 2/20 0.37
MCL1 Q07820 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899907 0.91 LMNA (0.41) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904182 0.91 LMNA (0.48) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905884 0.88 LMNA (0.46) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904123 0.86 LMNA (0.43) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4900979 0.84 SMN1; SMN2 (0.43) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4905062 0.83 ALDH1A1 (0.42) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904506 0.81 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4904660 0.81 LMNA (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906795 0.80 TARBP2 (0.41) LMNAALDH1A1HPGDHSD17B10KMT2A
SCHEMBL6507035 0.79 PPARA (0.42) LMNAALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.